Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression

Author(s): Xiao-Ting Zhou, Wen-Dai Bao, Dan Liu, Ling-Qiang Zhu*.

Journal Name: Current Neuropharmacology

Volume 18 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Depression is one of the prevalent psychiatric illnesses with a comprehensive performance such as low self-esteem, lack of motivation, anhedonia, poor appetite, low energy, and uncomfortableness without a specific cause. So far, the cause of depression is not very clear, but it is certain that many aspects of biological psychological and social environment are involved in the pathogenesis of depression. Recently, the prefrontal cortex (PFC) has been indicated to be a pivotal brain region in the pathogenesis of depression. And increasing evidence showed that the abnormal activity of the PFC neurons is linked with depressive symptoms. Unveiling the molecular and cellular, as well as the circuit properties of the PFC neurons will help to find out how abnormalities in PFC neuronal activity are associated with depressive disorders. In addition, concerning many antidepressant drugs, in this review, we concluded the effect of several antidepressants on PFC neuronal activity to better understand its association with depression.

Keywords: Depression, prefrontal cortex, circuit, molecular, synapse, drug.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [332 - 346]
Pages: 15
DOI: 10.2174/1570159X17666191101124017
Price: $65

Article Metrics

PDF: 12